Literature DB >> 12920755

Clinicopathologic relevance of asymptomatic endometrial carcinoma.

Toshiko Jobo1, Tsutomu Arai, Rinya Sato, Hiroyuki Kuramoto.   

Abstract

OBJECTIVE: To assess whether screening asymptomatic women is significant for early detection of endometrial carcinoma. STUDY
DESIGN: We compared the clinicopathologic findings and prognoses of 21 asymptomatic patients with 427 symptomatic patients with endometrial carcinoma.
RESULTS: The incidence of asymptomatic endometrial carcinoma was 4.7%. Nineteen of 21 asymptomatic patients with endometrial carcinoma were found by cytologic screening for endometrial cancer. There was a statistical difference in the histopathology and depth of myometrial invasion between the asymptomatic and symptomatic groups. However, no statistical differences were found in tumor grade, lymph node metastasis, adnexal metastasis, cervical invasion, peritoneal cytology, surgical stage and patient age. Univariate analysis showed that the presence or absence of symptoms was not related to survival.
CONCLUSION: The detection of asymptomatic endometrial carcinoma is not related to a reduced mortality rate. Screening asymptomatic women for endometrial carcinoma is not recommended.

Entities:  

Mesh:

Year:  2003        PMID: 12920755     DOI: 10.1159/000326577

Source DB:  PubMed          Journal:  Acta Cytol        ISSN: 0001-5547            Impact factor:   2.319


  2 in total

1.  Isolation of side population cells from endometrial cancer cells using a violet laser diode.

Authors:  Satoshi Tomiyasu; Tomoyuki Miyamoto; Michihiro Mori; Takahiro Yaguchi; Hiromasa Yakushiji; Setsuyo Ohno; Yasuyuki Miyake; Takuya Sakaguchi; Masatsugu Ueda; Eiji Ohno
Journal:  Hum Cell       Date:  2013-10-04       Impact factor: 4.174

2.  Next-generation sequencing analysis of endometrial screening liquid-based cytology specimens: a comparative study to tissue specimens.

Authors:  Toshiaki Akahane; Ikumi Kitazono; Shintaro Yanazume; Masaki Kamio; Shinichi Togami; Ippei Sakamoto; Sachio Nohara; Seiya Yokoyama; Hiroaki Kobayashi; Tsubasa Hiraki; Shinsuke Suzuki; Shinichi Ueno; Akihide Tanimoto
Journal:  BMC Med Genomics       Date:  2020-07-11       Impact factor: 3.063

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.